After Janssen Pharmaceuticals was found responsible for a middle school boy from Wisconsin who developed gynecomastia after taking the antipsychotic medicine Risperdal: generic risperidone), the Pennsylvania court that delivered the verdict now says punitive damages may be tacked on to the final bill.
Free Confidential Lawsuit Evaluation: If you or a loved one has been injured by the side effects of Risperdal, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.
What’s the Problem?
January 17, 2018 – Timothy Stange was just 12-years-old in 2006 when his doctor prescribed Risperdal to treat his Tourette’s syndrome, a neurological disorder characterized by repetitive involuntary movements and vocalizations called tics.
Manufactured and marketed by Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), Risperdal is an antipsychotic medicine that received clearance from the FDA in 2006 to treat symptoms of autism in pediatric and adolescent populations.
According to court documents, Stange felt a stabbing pain in his nipple in 2007, but stayed on Risperdal until 2009. Two years later, he noticed that his breasts had grown abnormally large, and was subsequently diagnosed with gynecomastia, a condition where an imbalance of the hormones estrogen and testosterone causes male breast tissue to swell.
Stange had both breasts removed (double mastectomy) at the age of 18 after enduring years of teasing by his classmates, the complaint states. He later joined a class action lawsuit in Philadelphia comprised of over 5,500 plaintiffs who claimed to have developed gynecomastia after taking Risperdal.
His complaint finally reached a jury in 2015, which awarded Stange over $500,000 in compensatory damages, which both parties appealed. Then on January 8, a three-member judicial panel ruled that Stange could also be awarded punitive damages for his injuries.
The panel found that the trial court left Wisconsin law out when it determined which state law governing punitive damages should apply. Janssen failed to sway the Superior Court panel that New Jersey law was correctly chosen “because the defendants’ principal places of business were in New Jersey, the Risperdal labeling was developed and distributed from New Jersey, Janssen’s overall Risperdal marketing and sales strategy was developed in New Jersey, and communications with the FDA and the medical community occurred in New Jersey.”
Do I Have a Risperdal Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Risperdal lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.
Free Case Evaluation: Again, if you’ve been harmed by Risperdal side effects, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.